Skip to main content
KDA GROUP INC. logo

KDA GROUP INC. — Investor Relations & Filings

Ticker · KDA TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 225 across all filing types
Latest filing 2025-05-21 Regulatory Filings
Country CA Canada
Listing TSXV KDA

About KDA GROUP INC.

https://groupkda.com

KDA Group Inc. is a global provider of technological and operational efficiency solutions focused on the digital transformation of the healthcare sector. The company serves general and specialized health markets, including the pharmaceutical industry. KDA develops advanced digital and artificial intelligence solutions, such as the Medherize platform and the Adherize+ pharmacological adherence software. Complementary services include specialized medical education, professional training, consulting, and resource placement. KDA's mission is to drive innovative development in global health systems using secure and human-centered technology.

Recent filings

Filing Released Lang Actions
News release - French.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing that Groupe KDA’s Adherize+ platform has obtained DSQ certification and that its Medherize module will begin clinical deployment. It is not a financial earnings release, regulatory report (e.g., 10-K, IR), management change notice, or any of the specific categories such as dividend, share issue, governance, M&A, etc. It is a general corporate announcement distributed for regulatory purposes (via SEDAR+). Therefore, it best fits the “Regulatory Filings” fallback category (RNS).
2025-05-21 French
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing that KDA Group has received DSQ (Dossier Santé Québec) certification for its Adherize+ platform and is entering a clinical deployment phase. It is not an earnings release, financial report, management change, or capital market filing. Instead, it is a general regulatory/approval announcement without detailed financials. This fits the fallback category for miscellaneous regulatory updates: Regulatory Filings (RNS).
2025-05-21 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive set of 'Consolidated Interim Financial Statements' for KDA Group Inc. for the six-month period ended January 31, 2025. It includes the Statement of Financial Position, Statement of Profit (Loss), Statement of Changes in Equity, Statement of Cash Flows, and detailed notes to the financial statements. This meets the definition of an Interim/Quarterly Report (IR) as it contains substantive financial data and analysis for a period shorter than a full fiscal year. H1 2025
2025-03-14 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “Management Discussion and Analysis” (MD&A) for the six-month periods ended January 31, 2025 and 2024. It provides management’s detailed discussion of financial results, operational highlights, forward-looking statements, and narrative explanations of the interim consolidated financial situation. This matches the definition of a Management Report (MDA), rather than an earnings release (ER) or interim report (IR) itself. It is too substantive to be a Regulatory Filing announcement (RNS/RPA) and does not fit other categories.
2025-03-14 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a 'Form 52-109FV2', which is a standard Canadian regulatory certification form for venture issuers. It serves as an officer attestation regarding the review and accuracy of interim filings. Per the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference interim reports, must be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive financial data. Q1 2025
2025-03-14 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a NI 52-109 Form 52-109FV2 “Certification of Interim Filings” by the CEO of a venture issuer. It is not the interim financial statements or MD&A themselves but a compliance certificate required under securities legislation. This is a regulatory compliance filing rather than the actual interim report, earnings release, or management discussion. It best fits into the fallback category for general regulatory filings (RNS).
2025-03-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.